Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis

BACKGROUND: Nearly 10% to 20% of myasthenia gravis (MG) patients are refractory to conventional treatment for unclear reasons. The study aimed to explore the relationship between drug metabolism gene polymorphisms and refractory MG. METHODS: One hundred and thirty-one MG patients (33 in the refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Ge, Huizhen, Gui, Mengcui, Yang, Mengge, Bi, Zhuajin, Ma, Xue, Gu, Zhongya, Peng, Shu, Chen, Tao, Bu, Bitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708465/
https://www.ncbi.nlm.nih.gov/pubmed/36467365
http://dx.doi.org/10.21037/atm-22-2543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708465/
https://www.ncbi.nlm.nih.gov/pubmed/36467365
http://dx.doi.org/10.21037/atm-22-2543

Ejemplares similares